Abstract:BACKGROUND: Hepatocyte transplantation has achieved some success in animal experiments for the treatment of metabolic diseases and acute liver failure. However, the clinical efficacy of hepatocyte transplantation is unsatisfactory. The difference between the experimental results and the clinical efficacy may be related to the hepatocyte transplantation approach. OBJECTIVE: To evaluate the therapeutic effects of hepatocyte transplantation by the intubation via the intubation of the splenic artery and intrasplenic injection in rats with acute hepatic failure, providing more optimal transplantation approaches and methods. METHODS: Hepatocytes were isolated and cultured by the modified Seglen's method (two-step). Acute hepatic failure was induced by D-gal in Sprague-Dawley rats (provided by the Experimental Animal Center of Chongqing Medical University in China). After 24 hours, an intubation tube was inserted into the splenic artery in 65 rats with acute hepatic failure, which was successful in 60 rats. Then these 60 rat models were randomly divided into three groups (n=20 per group). Intrasplenic injection group received about 2×107 hepatocytes through intrasplenic injection and 0.4 mL of Hank's solution through the splenic artery. Splenic artery group received 0.4 mL of Hank's solution through intrasplenic injection and 2×107 hepatocytes through the splenic artery. Model group received 0.4 mL of Hank's solution through intrasplenic injection and 0.4 mL of Hank's solution through the splenic artery. Survival rate and liver function of the rats was observed within 14 days after transplantation. The distribution of CFDA-SE-labeled hepatocytes transplanted via the splenic artery was observed under fluorescence microscope at 7 days after transplantation, and meanwhile, the distribution and proliferation of transplanted hepatocytes in the spleen were observed using hematoxylin-eosin staining. Synthesis of albumin in the spleen was observed by immunofluorescence staining. RESULTS AND CONCLUSION: (1) 80％-90％ hepatocytes survived after isolation. (2) At 14 days after transplantation, the survival rates of rats in the three groups were significantly different: intrasplenic injection group> splenic artery group> model group. (3) The liver function of rats was significantly improved in the intrasplenic injection group and the splenic artery group, especially in the former group. (4) CFDA-SE-labeled hepatocytes (green fluorescence) were scattered in the rat spleen and liver at 7 days after transplantation via the splenic artery. (5) At 14 days after transplantation, immunofluorescent staining of albumin demonstrated some positive cells in the rat spleen in the intrasplenic injection group and splenic artery group. (6) At 7 days after transplantation, transplanted hepatocytes were concentrated and colonized in the red pulp of the spleen. In conclusion, hepatocyte transplantation through catheterization of the splenic artery via carotid route can improve the survival of rats with acute hepatic failure and ameliorate the hepatic function, but intrasplenic injection is significantly superior to the injection via the splenic artery.

Isolation and transplantation of primary hepatocytes

[Treatment of Acute Liver Injury by Intrasplenic Transplantation of Hepatic Stem Cells Combined with Heparin in Rats].

Therapeutic effects of hepatocyte transplantation via two different intrasplenic approaches in acute hepatic failure rats

Transplantation of Monocyte-Derived Hepatocyte-Like Cells (neoheps) Improves Survival in A Model of Acute Liver Failure

IMPROVEMENT OF THE EFFECTS OF INTRASPLENIC TRANSPLANTATION OF HEPATOCYTES AFTER 90-PERCENT HEPATECTOMY IN THE RAT BY COTRANSPLANTATION WITH PANCREATIC-ISLETS

IMPROVEMENT OF THE EFFECTS OF INTRASPLENIC TRANSPLANTATION OF HEPATOCYTES AFTER 90% HEPATECTOMY IN THE RAT BY COTRANSPLANTATION WITH PANCREATIC ISLETS:

Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation.

In Vitro Culture of Isolated Primary Hepatocytes and Stem Cell-Derived Hepatocyte-Like Cells for Liver Regeneration

Comparison of therapeutic effects between catheterization of hepatic artery via carotid route and intrasplenic injection for hepatocyte transplantation in acute hepatic failure rats

Establishing a Model of Acute Hepatic Failure and a Preliminary Study of the Way of Cell Transplantation

Simplified Isolation and Spheroidal Aggregate Culture of Rat Hepatocytes.

Isolation, Culture and Intraspleenic Transplantation of Rat Hepatic Oval Cells

Separation of rat hepatocytes using modified collagenase perfusion via the abdominal aorta

Experimental study in the treatment of acute liver failure with intraperitoneal microencapsulated hepatocytes in rats

Study on the therapy of hepatic failure using hepatocyte-like cells derived from bone marrow transplantation

Transplantation of bone marrow-derived hepatocyte-like cells via the portal vein in rat hepatic fibrosis models

Advances in cell sources of hepatocytes for bioartificial liver.

Primary Hepatocyte Culture in Collagen Gel Mixture and Collagen Sandwich

[Isolation of Mouse Primary Hepatocytes by Retrograde Liver Perfusion with Catheterization Via Heart].

Microencapsulated Porcine Hepatocyte Transplantation to Treat Acute Hepatic Failure of Rats Induced by Drug

The effect of pancreatic islets on transplanted hepatocytes in the treatment of acute liver failure in rats.